This information was published on 2025-06-12T15:43:49 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2553992 (IR 1856843) |
| (220) |
21 May 2025
|
| (300) |
US, 27 Nov 2024, 98876370
|
| (511) (510) |
Class 5
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders. |
| (540) | JIDEYTRO |
| (550) | Word |
| (730) |
Nuvalent, Inc.
|
Find out more about publications on the About page.